{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"2.76","value":"5.60"},{"groupId":"OG001","spread":"1.89","value":"6.44"}]}],"title":"Average Daily Pain Intensity"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"2.45","value":"5.11"},{"groupId":"OG001","spread":"1.96","value":"5.98"}]}],"title":"Worst Daily Pain Intensity"}],"denoms":[{"counts":[{"groupId":"OG000","value":"42"},{"groupId":"OG001","value":"56"}],"units":"Participants"}],"description":"Patients in each arm will each have 9 measures: daily scores averaged over 1 week with baseline to week 8:\n\n1. Average daily pain intensity 0 (no pain) to 10 (worst) scale\n2. Worst daily pain intensity 0 (no pain) to 10 (worst) scale","dispersionType":"Standard Deviation","groups":[{"description":"Standard pain control drugs.","id":"OG000","title":"Standard of Care"},{"description":"Pain will be Monitored and Medication Titrated","id":"OG001","title":"Opioid Titration"}],"paramType":"MEAN","reportingStatus":"POSTED","timeFrame":"Baseline(Week 0) to week 8, Total time frame is 9 weeks.","title":"Pain Intensity","type":"PRIMARY","unitOfMeasure":"units on a scale"}